Tuberculosis is a chronic infection by Mycobacterium tuberculosis that results in over 1.5
million deaths worldwide each year. Currently, there is only one vaccine against …

The high incidence of tuberculosis (TB) in the world, especially in developing countries, the
resurgence of TB in industrialized countries, and the global increase in the prevalence of …

Mycobacterium vaccae, a bacterium found in soil, has been receiving attention as adjuvant
to antituberculosis treatment, vaccines and immunotherapies and even as antidepressant …

Nontuberculous mycobacteria (NTM) have been well established as an opportunistic
pathogenic bacterial group for cystic fibrosis (CF) patients, with a prevalence ranging from …

Immunotherapy represents a promising approach for improving current antibiotic treatments
through the engagement of the host's immune system. Latency-associated antigens have …

Asthma is a heterogeneous disease characterized by chronic airway inflammation. CD4 (+)
T-helper 9 (Th9) cells are closely linked to asthma, helping to regulate inflammation and …

Mycobacterium tuberculosis was one of the first human pathogens to be identified as the
cause of a specific disease–TB. TB was also one of the first specific diseases for which …

Tuberculosis (TB) remains a prevalent global infectious disease caused by genetically
closely related tubercle bacilli in Mycobacterium tuberculosis complex (MTBC). For a …

Background Mycobacterium vaccae nebulization imparted protective effect against allergic
asthma in a mouse model. The TGF-β/Smad signal transduction pathway plays an important …

Vaccination has been spectacularly successful in eradicating or controlling some infectious
diseases, and is particularly attractive as an approach to tackling other infectious diseases …